Adjunctive oral corticosteroids reduce renal scarring: The piglet model of reflux and acute experimental pyelonephritis

Journal of Urology

Volumn 162, Issue 3 I, 1999, Pages 815-820

  Pohl, Hans G ^a   Rushton, H Gil ^a   Park, Jae Shin ^a   Chandra, Roma ^a   Majd, Massoud ^a  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

Adrenal cortex hormones; Kidney; Pyelonephritis; Urinary tract infections

Indexed keywords

ANTIBIOTIC AGENT; CEFTRIAXONE; CORTICOSTEROID; COTRIMOXAZOLE; PREDNISOLONE;

ACUTE PYELONEPHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG EFFICACY; HISTOPATHOLOGY; INTRAMUSCULAR DRUG ADMINISTRATION; KIDNEY SCAR; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SWINE;

EID: 0032880227     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005392-199909010-00067     Document Type: Article

References (23)

1. Kauffman, H. M., McBride, M. A., Rosendale, J. D., Ellison, M. D., Daily, O. P. and Wolf, J. S.: Trends in organ donation, recovery and disposition: UNOS data for 1988-1996. Transplant Proc., 29: 3303, 1997.
2. Rushton, H. G., Majd, M., Jantausch, B., Wiedermann, B. L. and Belman, A. B.: Renal scarring following reflux and nonreflux pyelonephritis in children: evaluation with 99mtechnetium-dimercaptosuccinic acid. J. Urol., 147: 1327, 1992.
3. Rushton, H. G.: Urinary tract infections in children. Epidemiology, evaluation, and management. Ped. Clin. N. Amer., 44: 1133, 1997.
4. Roberts, J. A., Suarez, G. M. and Kaack, B.: Experimental pyelonephritis in the monley VII: ascending pyelonephritis in the absence of vesicoureteral reflux. J. Urol., 133: 1068, 1985.
5. Douzdjian, V., Abecassis, M. M., Cooper, J. L., Smith, J. L., Corry, R. J.: Incidence, management and significance of surgical complications after pancreatic transplantation. Surg. Gynec. & Obst., 177: 451, 1993.
6. Jakobsson, B., Soderlundh, S. and Berg, U.: Diagnostic significance of 99mtc-dimercaptosuccinic acid (DMSA) scintigraphy in urinary tract infection. Arch. Dis. Child., 67: 1338, 1992.
7. Skoog, S. J. and Belman, A. B.: A nonsurgical approach to the management of primary vesicoureteral reflux. J. Urol., part 2, 138: 941, 1987.
8. Glauser, M. P., Lyons, J. M. and Brande, A. I.: Prevention of chronic experimental pyelonephritis by suppression of acute suppuration. J. Clin. Invest., 61: 403, 1978.
9. Kallenius, G., Mollby, R. and Svensson, S. B.: The pK antigen as receptor for the hemagglutination of pyelonephritogenic Escherichia coli. FEMS Microbiol. Lett., 7: 297, 1980.
10. Lomberg, H., Hellstrom, M., Jodal, U., Leffler, H., Lincoln, K. and Svanborg-Eden C.: Virulence-associated traits in escherichia coli causing first and recurrent episodes of urinary tract infection in children with or without vesicoureteral reflux. J. Infect. Dis., 150: 561, 1984.
11. Marild, S., Wettergren, B., Hellstrom, M., Jodal, U., Lincoln, K., Orskov, I., Orskov, P. and Svanborg-Eden, C.: Bacterial virulence and inflammatory response in infants with febrile urinary tract infection or screening bacteriuria. J. Ped., 112: 348, 1988.
12. Svanborg-Eden, C., Andersson, B., Hagberg, L., et al: Receptor analogues and anti-pili antibodies as inhibitors of bacterial attachment in vivo and in vitro. Ann. New York Acad. Sci., 409: 580, 1983.
13. Weiss, S. J.: Tissue destruction by neutrophils. New Engl. J. Med., 320: 365, 1989.
14. Pfeilschifter, J., Eberhardt, W., Hummel, R., Kunz, D., Muhl, H., Nitsch, D., Pleiss, C. and Walker, G.: Therapeutic strategies for the inhibition of inducible nitric oxide synthase - potential for a novel class of anti-inflammatory agents. Cell Biol. Int., 20: 51, 1996.
15. Ginsburg, I. and Kohen, R.: Cell damage in inflammatory and infectious sites might involve a coordinated "cross-talk" among oxidants, microbial haemolysins and ampiphiles, cationic proteins, phospholipases, fatty acids, proteinases, and cytokines (an overview). Free Rad. Res., 22: 489, 1995.
16. Joyce, D. A., Steer, J. H. and Abraham, L. J.: Glucocorticoid modulation of human monocyte/macrophage function: control of TNF-alpha secretion. Inflamm. Res., 46: 447, 1997.
17. Cato, A. C. and Wade, E.: Molecular mechanisms of anti-inflammatory action of glucocorticoids. Bioessays, 18: 371, 1996.
18. Barnes, P. J.: Anti-inflammatory mechanisms of glucocorticoids. Biochem. Soc. Trans., 23: 940, 1995.
19. Schleimer, R. P.: An overview of glucocorticoid anti-inflammatory actions. Eur. J. Clin. Pharm., suppl., 45: S3, 1993.
20. McEver, R. P., Moore, K. L. and Cummings, R. D.: Leukocyte trafficking mediated by selectin-carbohydrate interactions. J. Bio. Chem., 270: 11025, 1995.
21. Goulding, N. J. and Guyre, P. M.: Glucocorticoids, lipocortins and the immune response. Gurr. Opin. Immun., 5: 108, 1993.
22. Brouhard, B. H.: Early (99m)tc dimercaptosuccinic acid (DMSA) scintigraphy in symptomatic first-time urinary tract infection. Clin. Fed., 36: 366, 1997.
23. Rushton, H. G. and Majd, M.: Dimercaptosuccinic acid renal scintigraphy for the evaluation of pyelonephritis and scarring: a review of experimental and clinical studies. J. Urol., 148: 1726, 1992.